With the help of a very unique, however a simple technique the scientist at RightEye have confirmed the outstanding performance of hyperbaric oxygen therapy (HBOT).
They have diagnosed the brain health with the help of eye examination.
HBOT is defined as the breathing of 100% oxygen at higher than atmospheric pressure in a pressurized chamber. When a person is healthy, the blood cells are full of oxygen even at a normal pressure and cannot accept any more of it.
At elevated pressure oxygen is dissolved into all of the body’s fluids, the plasma. This oxygen then reaches damaged tissue through the bloodstream. Breathing pure oxygen at increased atmospheric pressure enables the body to receive up to 10 times more oxygen, delivered to all tissues in the body to promote effective healing, recovery and rejuvenation. The increased oxygen can greatly enhance the ability of white blood cells to kill bacteria, reduce swelling, and allow new blood vessels to grow more rapidly into the affected areas.
When a person is suffering from mild traumatic brain injury, HBOT can increase tissue oxygenation in the brain and restores blood supply to the compromised region of the brain. Many research studies show effectiveness of HBOT in improving brain function and quality of life of patients with mild traumatic brain injury.
From now on, we have another way to prove the outstanding performance of HBOT. It is available only from eye examination, the non-invasive series of tests and examinations pertaining to eyes. “RightEye uses advanced eye-tracking technology and scientifically verified protocols to give patients a deeper, clearer evaluation of their brain’s levels of activity.”
The test “uncovers eye-movement patterns and functional vision issues that may be the result of neurological problems and helps care providers quantify changes. And it provides all of this data in a nice, neat, easy-to-read report.” The beauty of the test is in quantification of results.
One of the tests was done on 45-year-old war veteran that was previously diagnosed with Post-Traumatic Stress Disorder (PTSD) and migraine.
The statistics show that his EyeQ was very low, 32 on the scale from 0 to 100, indicating dysfunctionality. His reaction time (eye-hand reaction) was 1.302 ms, compared to average, he was on 75% accuracy.
The assessment of his brain activity was done again after 27 days of HBOT treatments. He has done 20 treatments in hyperbaric chamber on 2.0 ATA of pressure.
His EyeQ was 76, indicating improvements in functionality. His reaction time (eye-hand reaction) was 1.022 ms, compared to average, he was on 100% accuracy.
“RightEye Brain Health EyeQ metrics showed a significant improvement in most eye movement behaviors for acutely concussed patients undergoing HBOT:
- Improved oculomotor behavior correlated with improved symptoms in most cases.
- This technology may help to provide objective evidence of the efficacy of early concussion interventions, such as HBOT.”
AHA Hyperbarics’ CEO, Peter Kokalj has also tested the technology to be on the safe side and checked his brain health. His EyeQ is excellent, 93 on the scale from 0 to 100. This is of course no surprise for us, as he is using AHA chamber regularly.
In case of mild traumatic brain injury there is published literature supporting HBOT’s efficacy. And now we have also Brain Health EyeQ that seems to offer an objective measurement of effectiveness of HBOT on brain injuries. It can transform our ability to effectively treat mild traumatic brain injury patients of all kinds by identifying precise issues with eye movement that lead to headaches, balance issues and post-concussion syndrome.